Integrative analysis of large-scale loss-of-function screens identifies robust cancer-associated genetic interactions by Christopher J Lord, Niall Quinn, Colm J Ryan

Get full text

High-Temperature Live-Cell Imaging of Cytokinesis, Cell Motility, and Cell-Cell Interactions in the Thermoacidophilic Crenarchaeon Sulfolobus acidocaldarius by Arthur Charles-Orszag, Samuel J. Lord, R. Dyche Mullins

Get full text

Resistance to DNA repair inhibitors in cancer by Joseph S. Baxter, Diana Zatreanu, Stephen J. Pettitt, Christopher J. Lord

Get full text

Beyond DNA repair: the novel immunological potential of PARP inhibitors by Roman M. Chabanon, Jean-Charles Soria, Christopher J. Lord, Sophie Postel-Vinay

Get full text

Extrapolating evidence for molecularly targeted therapies from common to rare cancers: a scoping review of methodological guidance by Sarah J Lord, Saskia Cheyne, John Simes, Doah Cho, Chee Khoon Lee

Get full text

A cluster randomised, 16-week, parallel-group multicentre trial to compare the effectiveness of a digital school-based cognitive behavioural resilience/wellbeing-building intervent... by S. Jolley, J. Lord, D. Plant, E. Wood, K. Bracegirdle, S. Browning, B. Carter, K. James

Get full text

Global prevalence of hospital admissions for low back pain: a systematic review with meta-analysis by Christopher G Maher, Gustavo C Machado, Joshua Zadro, Danielle Coombs, Alla Melman, Harrison J Lord

Get full text

Trastuzumab emtansine for HER2-positive metastatic breast cancer: Outcomes from a whole-of-population Australian cohort by Benjamin Daniels, Belinda E. Kiely, Monica Tang, Nehmat Houssami, Sarah J. Lord, Sallie-Anne Pearson

Get full text

Adhesion pilus retraction powers twitching motility in the thermoacidophilic crenarchaeon Sulfolobus acidocaldarius by Arthur Charles-Orszag, Marleen van Wolferen, Samuel J. Lord, Sonja-Verena Albers, R. Dyche Mullins

Get full text

Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast Cancer by Agnieszka K. Witkiewicz, Sejin Chung, Rachel Brough, Paris Vail, Jorge Franco, Christopher J. Lord, Erik S. Knudsen

Get full text

Opinion: PARP inhibitors in cancer—what do we still need to know? by Andrew J. Wicks, Dragomir B. Krastev, Stephen J. Pettitt, Andrew N. J. Tutt, Christopher J. Lord

Get full text

Synthetic lethality of PARP and NAMPT inhibition in triple‐negative breast cancer cells by Ilirjana Bajrami, Asha Kigozi, Antoinette Van Weverwijk, Rachel Brough, Jessica Frankum, Christopher J. Lord, Alan Ashworth

Get full text

Next-generation sequencing, should I use anti-HER2 therapy for -amplified tumors off-label? Illustrating an extrapolation framework by Doah Cho, Sarah J. Lord, John Simes, Wendy Cooper, Michael Friedlander, Susie Bae, Chee Khoon Lee

Get full text

Longitudinal analysis of a secondary BRCA2 mutation using digital droplet PCR by Saira Khalique, Stephen J Pettitt, Ger Kelly, Nina Tunariu, Rachael Natrajan, Susana Banerjee, Christopher J Lord

Get full text

Adherence to prescribing restrictions for HER2-positive metastatic breast cancer in Australia: A national population-based observational study (2001-2016). by Benjamin Daniels, Federico Girosi, Hanna Tervonen, Belinda E Kiely, Sarah J Lord, Nehmat Houssami, Sallie-Anne Pearson

Get full text

Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysis by Katrin M. Sjoquist, Sarah J. Lord, Michael L. Friedlander, Robert John Simes, Ian C. Marschner, Chee Khoon Lee

Get full text

Coupling bimolecular PARylation biosensors with genetic screens to identify PARylation targets by Dragomir B. Krastev, Stephen J. Pettitt, James Campbell, Feifei Song, Barbara E. Tanos, Stoyno S. Stoynov, Alan Ashworth, Christopher J. Lord

Get full text

Prediction of pre-eclampsia in nulliparous women using routinely collected maternal characteristics: a model development and validation study by Ziad T. A. Al-Rubaie, H. Malcolm Hudson, Gregory Jenkins, Imad Mahmoud, Joel G. Ray, Lisa M. Askie, Sarah J. Lord

Get full text

Employer-Sponsored Health Centers Provide Access to Integrated Care via a Hybrid of Virtual and In-Person Visits by Divya K. Madhusudhan, Sharon A. Watts, Daniel J. Lord, Fiona Ding, David C. Lawrence, Austin Sheldon, James Leonard, Dena M. Bravata

Get full text

Cross-species identification of PIP5K1-, splicing- and ubiquitin-related pathways as potential targets for RB1-deficient cells. by Andrey A Parkhitko, Arashdeep Singh, Sharon Hsieh, Yanhui Hu, Richard Binari, Christopher J Lord, Sridhar Hannenhalli, Colm J Ryan, Norbert Perrimon

Get full text